World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615000714583
Date of registration: 10/07/2015
Prospective Registration: Yes
Primary sponsor: Dr Melissa Day
Public title: Coping Skills Training for Living With Chronic Low Back Pain
Scientific title: Mechanisms of Mindfulness Meditation, Cognitive Therapy, and Mindfulness-Based Cognitive Therapy for Low Back Pain
Date of first enrolment: 20/01/2016
Target sample size: 63
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12615000714583.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Dr Melissa Day   
Address:  330 McElwain Building School of Psychology The University of Queensland Brisbane, QLD 4072 Australia
Telephone: +61 7 3365 6421
Email: m.day@uq.edu.au
Affiliation: 
Name: Dr Melissa Day   
Address:  330 McElwain Building School of Psychology The University of Queensland Brisbane, QLD 4072 Australia
Telephone: +61 7 3365 6421
Email: m.day@uq.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: (1) at least 18 years of age; (2) chronic pain of the low back (at least 3 months) that is the primary source of reported pain; (3) average pain intensity of at least 4 on a 10-point scale; (4) if currently taking analgesic or psychotropic medications, they must have been stabilised for at least 4 weeks prior to this study; (5) be able to read, speak and understand English; and (6) be able to attend a weekly 2-hour therapy session for 8 concurrent weeks.
Exclusion criteria: (1) cognitive impairment, uncontrolled psychotic symptoms or current elevated suicidal ideation as this may interfere with group-delivered therapy (as evidenced by the 6-item screener); (2) chronic pain due to malignancy; (3) history of a medical condition that could produce an abnormal EEG and interfere with the tests of the effects of treatment on EEG (e.g., epilepsy, history of traumatic brain injury); and (4) currently receiving other psychosocial pain treatment.

Age minimum: 18 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Low back pain;
Low back pain
Alternative and Complementary Medicine - Other alternative and complementary medicine
Musculoskeletal - Other muscular and skeletal disorders
Intervention(s)
Eight, group delivered 2 hours sessions (1 per week) of either:

(1) mindfulness meditation - various mindfulness meditation techniques are taught as means to reduce stress and improve coping and management of pain.

or

(2) cognitive therapy - exercises such as cognitive restructuring are taught to change unhelpful ways of thinking and responding to pain to improve pain management.

or

(3) mindfulness-based cognitive therapy - both mindfulness meditation and cognitive coping techniques are taught to improve adaptive pain coping and management.

Each participant receives all 8 sessions for one of the above three interventions only. Between session practice is encouraged and recorded via participant self-report. All interventions are group delivered by a clinical psychologist.
Primary Outcome(s)
Pain Interference, assessed via the PROMIS pain interference scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
Secondary Outcome(s)
Pain catastrophizing, assessed via the Pain Catastrophizing Scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
Pain intensity, assessed via a numerical rating scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
Psychological functioning, assessed via the PROMIS scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
Pain acceptance, assessed via the CPAQ[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
Physical functioning, assessed via the PROMIS scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
Emotional functioning, assessed via the PROMIS scale[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
Mindfulness, assessed via the FFMQ[Pre to post-treatment, i.e., baseline and after 8 weeks of treatment]
Secondary ID(s)
Nil Known
Source(s) of Monetary Support
National Health and Medical Research Council
Secondary Sponsor(s)
Nil known
Ethics review
Status: Approved
Approval date:
Contact:
Behavioural & Social Sciences Ethical Review Committee
Status: Approved
Approval date:
Contact:
Metro South Hospital and Health Service Human Research Ethics Committee
Results
Results available: Yes
Date Posted: 17/05/2019
Date Completed: 30/06/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history